Pathophysiology and Disease Mechanisms

Alzheimer’s disease is a progressive dementia with loss of neurons and the presence of two main microscopic neuropathological hallmarks: extracellular amyloid plaques and intracellular neurofibrillary tangles. Early onset AD, a rare familial form, is caused due to mutation of one out of three genes: (amyloid precursor protein), (presenilin 2) or (presenilin 1).  Sporadic form occurs usually after age of 65 and accounts for most cases; it most likely results from a combination of genetic and influence of environment. Confirmed risk factors for sporadic AD are age and the presence of the E4 allele of (Apo lipoprotein E). Amyloid plaques comprise mainly of the neurotoxic peptide amyloid (Aβ, Abeta), cleaved sequentially from a larger precursor protein (APP) by two enzymes: β-secretase (also called BACE1) and γ-secretase (comprising four proteins, presenilin is one of them). If APP is first cleaved by the enzyme α-secretase rather than β-secretase then Aβ is not formed. Neurofibrillary tangles comprise mainly of the protein tau which binds with microtubules, which facilitating the neuronal transport system. Tau uncoupling from microtubules and aggregation into tangles inhibits transport and results in disassembly of microtubule. Phosphorylation of tau might have an important role in this. Selective vulnerability of neuronal systems such as the cholinergic, serotonergic, and noradrenergic and glutamatergic systems form the basis of current rational pharmacological treatment.

This session includes Aging, Prions and Alzheimer’s disease, Cellular signaling and cell to cell transmission, Oxidative damage and mitochondrial dysfunction, Autoimmunity in Alzheimer’s, Blood-brain barrier and transport, Neurogenesis and stem cells and Cell death.

  • Aging
  • Prions and Alzheimer’s disease
  • Cellular signaling and cell to cell transmission?
  • Oxidative damage
  • Mitochondrial dysfunction
  • Autoimmunity in Alzheimer’s
  • Blood-brain barrier and transport
  • Neurogenesis and stem cells
  • Cell death

Related Conference of Pathophysiology and Disease Mechanisms

September 15-16, 2016

2nd International Conference on Autism

Phoenix, Arizona,USA
September 21-23, 2016

8th European Neurology Congress

Amsterdam, Netherlands
September 28-30, 2016

6th World Congress on Neurology and Neurological disorders

Toronto, Canada
September 29-October 01, 2016

5th International Conference on Alzheimer’s Disease & Dementia

London, UK
November 07-08, 2016

International Conference on Neurocognitive Disorders

Barcelona,Spain
November 21-23, 2016

9th Global Neuroscience Conference

Melbourne, Australia
February 27th - March 01st, 2017

6th International Conference on Vascular Dementia

Amsterdam, Netherlands
February 27-28, 2017

10th International Conference on Neuroscience and Neurochemistry

Amsterdam, Netherlands
March 27-29, 2017

11th World Congress on Neurology and Therapeutics

Madrid, Spain
April 17-19, 2017

3rd International Conference on Spinal Surgery

Zurich, Switzerland
April 27-28, 2017

International Conference on Inorganic Chemistry

Las Vegas, USA
August 06-07, 2017

13th International Conference on Child Neurologists

Birmingham, UK

Pathophysiology and Disease Mechanisms Conference Speakers

Recommended Sessions

Related Journals

Are you interested in